Please assess the completion status of the following clinical trial:

Trial Title: Thiamine Responsive Disorders (TRD) Among Infants in Lao PDR

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria of hospital-based children:~* 21 days to \<18 months and seeking care at the collaborating hospital and meeting at least one of the following inclusion criteria:~* Liver enlargement (\>2 cm below right costal margin on calm, supine exam)~* Edema~* Tachypnea (\> 60/min for 3-8 wks; \>50/min for 2-11 mo; \>40/min for 12 - 18 mo)~* Tachycardia (heart rate \>160/min for \<12 mo; \>120/min for 12 mo - 18 mo)~* Oxygen saturation (\<92%)~* Difficulty breathing (i.e. chest in-drawing, nasal flaring)~* Refusal to breastfeed or refusal of infant formula or food for greater than 24 hours~* Repetitive or recurring vomiting with no obvious other cause(i.e. vomiting \>3 times in past 24 hours)~* Persistent crying not relieved by soothing and feeding with no obvious other cause~* Hoarse voice/cry or loss of voice~* Nystagmus or other unusual eye movement~* Muscle twitching~* Loss of consciousness~* Convulsion~* Opisthotonus / abnormal posturing~* Acute paralysis / flaccid paralysis~Exclusion criteria of hospital-based children:~- None~Inclusion criteria of community-based children, who will be frequency-matched based on sex, age and residence to hospital-based participants :~* Children aged 21 days to \<18 months~* Residing in selected communities~Exclusion criteria of community-based children:~- Severe acute illness warranting immediate hospital referral~Inclusion criteria of participants' mothers:~- Mother of hospital-based study participant or community-based study participant~Exclusion criteria of participants' mothers:~* Severe acute illness warranting immediate hospital referral~* Unable to provide informed consent due to reduced decision making ability

- Gender: ALL
- Minimum Age: 21 Days
- Maximum Age: 17 Months
- Healthy Volunteers: t

Study Arms:
- Hospital-based cohort (Type: None): 100 mg thiamine provided via intramuscular and/or intravenous injection (Thiamine 100 MG/ML) daily for 3 days
- Community-based cohort (Type: None): Sex-, age- and regionally matched comparison group

Based on this trial design, predict the completion outcome and termination type (if applicable).